Binding and activity of the nine possible regioisomers of myo-inositol tetrakisphosphate at the inositol 1,4,5-trisphosphate receptor

Cell Calcium

Volumn 21, Issue 4, 1997, Pages 301-310

  Burford, Neil T ^a,c   Nahorski, Stefan R ^a   Chung, Sung Kee ^b   Chang, Young Tae ^b   Wilcox, Robert A ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INOSITOL TETRAKISPHOSPHATE; PARTIAL AGONIST;

ADRENAL CORTEX; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CALCIUM MOBILIZATION; CATTLE; CELL MEMBRANE; CHO CELL; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

EID: 0030983635     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4160(97)90118-4     Document Type: Article

References (50)

1. Chung S-K., Chang Y-T. Synthesis of all possible regioisomers of myo-inositol tetrakisphosphate. J Chem Soc Chem Commun 1995; 11-13.
2. Berridge M.J. Inositol trisphosphate and calcium signalling. Nature 1993; 361: 315-325.
3. Mourey R.J., Estevez V.A., Marecek J.F. et al. Inositol 1,4,5-trisphosphate receptors: Labelling the inositol-trisphosphate binding site with photoaffinity ligands. Biochemistry 1993; 32: 1719-1726.
4. Yoshikawa F., Morita M., Monkawa T., Michikawa T., Furuichi T., Mikoshiba K. Mutational analysis of the ligand-binding site of the inositol 1,4,5-trisphosphate receptor. J Biol Chem 1996; 271: 18277-18284.
5. Nahorski S.R., Potter B.V.L. Interaction of inositol polyphosphate analogues with intracellular receptors. In: Krogsgaard-Larsen P., Brogger Christensen S., Kofod H. (Eds) New Leads and Targets in Drug Research. Copenhagen: Munksgaard, 1992; 211-223.
6. Potter B.V.L, Nahorski S.R. Synthetic inositol polyphosphates and analogues as molecular probes for neuronal second messenger receptors. In: Kozikowski A.P. (Ed) Drug Design for Neuroscience. New York: Raven, 1993; 383-416.
7. 2+ by inositol 1,4,5-trisphosphate. Biochem J 1988; 253: 901-905.
8. Taylor C.W., Berridge M.J., Cooke A.M., Potter B.V.L. Inositol 1,4,5-trisphosphorothioate, a stable analogue of inositol trisphosphate which mobilises intracellular calcium. Biochem J 1989; 239: 645-650.
9. 2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase. Mol Pharmacol 1991; 39: 754-761.
10. 2+ mobilization in SH-SY5Y cells. Biochem J 1991; 276: 163-167.
11. Wilcox R.A., Safrany S.T., Lampe D. et al. 2-position modification of myo-inositol 1,4,5-trisphosphate produces inositol tris- and inositol tetrakisphosphates with potent biological activities. Eur J Biochem 1994; 223: 115-124.
12. 2+ release requirements for high affinity interactions with the myo-inositol 1,4,5-trisphosphate receptor. J Biol Chem 1994; 269: 26815-26827.
13. 2+ signalling? In: Liscovitch M. (Ed.) Signal-activated Phospholipases. Austin: R.G. Landes, 1994; 189-212.
14. Hill T.D., Berggren P-O., Boynton A.L. Heparin inhibits inositol trisphosphate-induced calcium releases from permeabilized rat liver cells. Biochem Biophys Res Commun 1987; 149: 897-901.
15. Ghosh T.K., Eis P.S., Mullancy J.M., Ebert C.L., Gill D.L. Competitive, reversible and potent antagonism of inositol 1,4,5-trisphosphate-activated calcium release by heparin. J Biol Chem 1988; 263: 11075-11079.
16. Fohr K.J., Scott J., Ahnert-Hilger G., Gratzl M. Characterization of the inositol 1,4,5-trisphosphate-induced calcium release from permeabilized endocrine cells and its inhibition by decavanadate and p-hydroxymercuribenzoate. Biochem J 1989; 262: 83-89.
17. Strupish J., Wojcikiewicz R.J.H., Challiss R.A.J. et al. Decavanadate interacts with inositol polyphosphate binding sites and is a competitive antagonist of the inositol 1,4,5-trisphosphate receptor. Mol Neuropharmacol 1991; 1: 111-116.
18. Takahashi M., Tanzawa K., Takahashi S. Adenophostins, newly discovered metabolites of Penicillium brevicompactum, act as potent agonists of the inositol 1,4,5-trisphosphate receptor. J Biol Chem 1994; 269: 369-372.
19. Wilcox R.A., Erneux C., Primrose W.U., Gigg R., Nahorski S.R. 2-hydroxyethyl α-D-glucopyranoside 2,3′,4′-trisphosphate a novel metabolically resistant adenophostin A and myo-inositol 1,4,5-trisphosphate analogue potently interacts with the myo-inositol 1,4,5-trisphosphate receptor. Mol Pharmacol 1995; 47: 1204-1211.
20. Gou D-M., Chen C-S. An efficient route to D-myo-inositol 1,4,5-trisphosphate and D-myo-inositol-1,3,4,5-tetrakisphosphate. Tetrahedron Lett 1992; 33: 721-724.
21. 3H]-inositol(1,4,5)-trisphosphate binding sites in adrenal cortical membranes. Biochem J 1990; 265: 421-427.
22. 2+ indicators with greatly improved fluorescent properties. J Biol Chem 1985; 260: 3440-3449.
23. 2+ and fluo-3. Methods Mol Biol 1995; 41: 215-227.
24. McPherson G.A. Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC. J Pharmacol Methods 1985; 14: 213-228.
25. 50) of an enzyme reaction. Biochem Pharmacol 1973; 22: 3099-3108.
26. Hirata M., Narumoto N., Watanabe Y. et al. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate. Mol Pharmacol 1994; 45: 271-276.
27. 3-like calcium mobilizing analogs. Bioorg Med Chem Lett 1995; 5: 1295-1300.
28. Shears S.B. Metabolism of inositol phosphates. Adv Second Messenger Research 1992; 26: 63-92.
29. Wilcox R.A., Whitham E.M., Liu C., Potter B.V.L., Nahorski S.R. Myo-Inositol 1,3,4,5-tetrakisphosphate can independently mobilise intracellular calcium, via the inositol 1,4,5-trisphosphate receptor: studies with myo-inositol 1,4,5-trisphosphate-3-phosphorothioate and myo-inositol hexakisphosphate. FEBS Lett 1993; 336: 267-271.
30. Nunn D.L., Taylor C.W. Liver inositol 1,4,5-trisphosphate-binding sites are the calcium mobilizing receptor. Biochem J 1990; 270: 227-232.
31. 2+-mobilizing properties of synthetic fluoro-analogues of myo-inositol 1,4,5-triphosphate and their interaction with myo-inositol 1,4,5-trisphosphate 3-kinase and 5-phosphatase. FEBS Lett 1990; 276: 91-94.
32. Wilcox R.A, Sawyer D.A., Liu C., Nahorski S.R., Potter B.V.L. The role of the 2 and 3-hydroxyl groups of 1D-myo-inositol 1,4,5-trisphosphate in calcium mobilization from permeabilized human 132IN1 astrocytoma cells. Carbohydr Res 1992; 234: 237-246.
33. Lu P-J., Gou D-M., Shieh W-R., Chen C.S. Molecular interactions of endogenous D-myo-inositol phosphates with the intracellular D-myo-inositol 1,4,5-trisphosphate recognition site. Biochemistry 1994; 33: 11586-11597.
34. Polokoff M.A., Bencen G.H., Vacca J.P. et al. Metabolism of synthetic inositol trisphosphate analogs. J Biol Chem 1988; 263: 11922-11927.
35. Gou D-M., Shieh W-R., Lu P-J., Chen C-S. D-myo-inositol 1,4,5-trisphosphate analogues as useful tools in biochemical studies of intracellular calcium mobilization. Bioorg Med Chem 1994; 2: 7-13.
36. 2+ mobilization. Biochem J 1993; 294: 191-194.
37. Wilcox R.A., Challiss R.A.J., Liu C., Potter B.V.L., Nahorski S.R. Inositol 1,3,4,5-tetrakisphosphate-induces calcium mobilization via the inositol 1,4,5trisphosphate receptor in SH-SY5Y cells. Mol Pharmacol 1993; 44: 810-817.
38. 6. Trends Biochem Sci 1993; 18, 53-56.
39. Ivorra I., Gigg R., Irvine R.F., Parker I. Inositol 1,3,4,6-tetrakisphosphate mobilizes calcium in Xenopus oocytes with high potency. Biochem J 1991; 273: 317-321.
40. 4. Nature 1994; 371: 711-714.
41. Mattingly R.R., Stephens L.R., Irvine R.F., Garrison J. Effects of transformation with the v-src oncogene on inositol phosphate metabolism in rat-1 flbroblasts. J Biol Chem 1991; 266: 15144-15153.
42. Barker C.J., Wong N.S., MacCallum S.H. et al. The interrelationships of the inositol phosphates formed in vasopressin-stimulated WRK-1 rat mammary tumour cells. Biochem J 1994; 286: 469-474.
43. Van Dijken P., De Haas J-R., Craxton A. et al. A novel, phospholipase C-independent pathway of inositol 1,4,5-trisphosphate formation in Dictyostelium and rat liver. J Biol Chem 1995; 270: 29724-29731.
44. Hirata M., Watanabe Y., Yoshida M., Koga T., Ozaki S. Role for hydroxyl groups of D-myo-inositol 1,4,5-trisphosphate in the recognition by its receptor and metabolic enzymes. J Biol Chem 1993; 268: 19260-19266.
45. Kozikowski A.P., Ognyanov V.I., Fauq A.H., Nahorski S.R., Wilcox R.A. Synthesis of 1D-3-deoxy-, 1D-2,3-dideoxy-, and 1D-2,3,6-trideoxy-myo-inositol 1,4,5-trisphosphate from quebrachitol, their binding affinities and calcium release activity. J Am Chem Soc 1993; 115: 4429-4434.
46. 2+ mobilization and enzyme recognition. Eur J Pharmacol 1992; 226: 265-272.
47. Safrany S.T., Wilcox R.A., Liu C. et al. Identification of partial agonists with low intrinsic activity at the inositol 1,4,5-trisphosphate receptor. Mol Pharmocol 1993; 43: 499-503.
48. 2+ mobilizing partial agonists at the inositol 1,4,5-trisphosphate receptor. Bioorg Med Chem Lett 1995; 5: 203-208.
49. DeLisle S., Radenberg T., Wintermantel M.R. et al. Second messenger specificity of the inositol trisphosphate receptor: reappraisal based on novel inositol phosphates. Am J Physiol 1994; 266: C429-C436.
50. Gawler D.J., Potter B.V.L, Nahorski S.R. Inositol 1,2,3,5-tetrakisphosphate-induced release of intracellular Ca2+ in SH-SY5Y neuroblastoma cells. Biochem J 1990; 272: 519-524.